#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Mucopolysaccharidosis II Hodgkin's disease recurrent Crohn's disease Squamous cell carcinoma of the oral cavity T-cell type acute leukaemia Anti-myelin-associated glycoprotein associated polyneuropathy Systemic lupus erythematosus Diffuse large B-cell lymphoma refractory Plasma cell myeloma Atopic keratoconjunctivitis Malignant oligodendroglioma Adenocarcinoma pancreas Acute myeloid leukaemia recurrent Hepatitis B Hypertriglyceridaemia More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia – Treatment Haemophilia B with anti factor IX – Treatment Alport’s syndrome – Basic Information Idiopathic pulmonary fibrosis – Treatment Carcinoid syndrome – Diagnostics Congenital hypotransferrinaemia – Treatment Systemic mastocytosis – Trials in Disease Methylmalonic acidaemia Aicardi-Goutieres syndrome – Diagnostics Hairy cell leukaemia recurrent – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gskvx000000017033 Mdna11 Pyridoxine Lenzumestrocel KETOROLAC TROMETAMOL Siremadlin Azd3470 Copper (64Cu) Chloride Fianlimab Bgb-15025 Citrate Fluconazole Gedatolisib Olopatadine Jab-21822 ALKYLATING AGENTS Sodium Fluoride (18F) Micafungin RO7795081 Cangrelor Tetrasodium IMA401 More therapies…

    Learn about Your Condition

    Febrile neutropenia Rasmussen encephalitis Circulatory collapse Vulval cancer Liver transplant rejection Turner's syndrome Pancreatic carcinoma Arterial disorder Tumour thrombosis Breast cancer Metastases to lymph nodes Leiomyosarcoma metastatic Vulvovaginal pain Generalised anxiety disorder Angiosarcoma metastatic More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Ospedaliera di Padova

Azienda Ospedaliera di Padova

Via Nicolo' Giustiniani 2, Padua, 35128, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness of Atenativ for Patients with Congenital Antithrombin Deficiency Undergoing Surgery or Childbirth

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Antithrombin III deficiency
    Investigated Drugs:
    • Antithrombin Iii Human
    • Human Plasma Derived Antithrombin
    Austria Czechia France Germany Hungary Italy +2

  • Study on the Safety and Effectiveness of GSK4532990 for Adults Aged 18-65 with Alcohol-Related Liver Disease

    Recruiting

    2 1
    Investigated Diseases:
    • Alcoholic liver disease
    Denmark France Germany Greece Italy Poland +2

  • Study on the Effects of ELGN-2112 (Human Insulin) for Treating Intestinal Malabsorption in Preterm Infants

    Recruiting

    3 1
    Investigated Drugs:
    • Insulin Human
    Austria France Italy The Netherlands Spain Sweden

  • Study of Dasatinib and Venetoclax for Children with Relapsed or Refractory Leukemia or Lymphoma with MAPK/SRC Pathway Mutation

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    • Precursor B-lymphoblastic lymphoma recurrent
    • Precursor B-lymphoblastic lymphoma refractory
    Investigated Drugs:
    • Dasatinib
    • Venetoclax
    Austria Belgium Denmark Finland France Germany +5

  • A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

    Recruiting

    3 1
    Investigated Drugs:
    • Elafibranor
    Austria Belgium Czechia Denmark Finland France +9

  • Long‑Term Safety Study of ADX‑324 in Participants with Hereditary Angioedema (Phase 3 Extension)

    Recruiting

    3 1
    Investigated Drugs:
    • ADX-324
    Austria Belgium Bulgaria Croatia Czechia France +5

  • A Phase 3 Study of Efimosfermin Alfa to Assess Safety and Tolerability in Adults with F2‑F3 Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Austria Belgium Bulgaria France Germany Greece +4

  • Safety and Efficacy of Efimosfermin Alfa in Participants with Biopsy‑Confirmed F2‑ or F3‑Stage Metabolic Dysfunction‑Associated Steatohepatitis (MASH)

    Recruiting

    3 1
    Investigated Diseases:
    • Metabolic dysfunction-associated steatohepatitis
    Austria Belgium Bulgaria France Germany Greece +4

  • Evaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Systemic lupus erythematosus
    Investigated Drugs:
    • Anifrolumab
    France Germany Italy Poland Spain

  • VMX-C001 in Patients Taking Factor Xa Inhibitors Who Need Urgent Surgery or an Invasive Procedure With High Bleeding Risk

    Recruiting

    3 1 1
    Investigated Drugs:
    • VMX-C001
    Austria Belgium Bulgaria Czechia Estonia France +9
Previous Page
1 … 15 16 17 18 19 … 41
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!